TA-2005,a Novel, Long-Acting, and Selective β_2-Adrenoceptor Agonist : Characterization of Its in Vivo Bronchodilating Action in Guinea Pigs and Cats in Comparison with Other β_2-Agonists
スポンサーリンク
概要
- 論文の詳細を見る
Relaxant effects of the β_2-selective adrenoceptor agonist TA-2005 on bronchoconstriction in the anesthetized guinea pig and cat were evaluated in comparison with other known β_2-adrenoceptor agonists. The ED_<50> values of intravenously administered TA-2005,procaterol, formoterol, isoproterenol, salbutamol, and salmeterol to inhibit the histamine-induced bronchoconstriction of the guinea pigs were 0.024,0.053,0.056,0.099,0.23,and 2.00μg/kg, respectively, and those in serotonin-challenged cats were 0.019,0.037,0.039,0.042,0.13,and 0.52μg/kg, respectively, in the same increasing order. When guinea pigs were passively sensitized with anti-ovalbumin antiserum, the ED_<50> values of TA-2005,formoterol, procaterol, and isoproterenol to inhibit the antigen-induced bronchoconstriction were 0.09,0.30,0.65,and 7.0μg/kg, i.v., respectively, while those of TA-2005,procaterol, formoterol, and salbutamol in actively sensitized animals were 0.24,0.25,1.40,and 23.0μg/kg. When TA-2005 was administered by inhalation to guinea pigs or by the intraduodenal route to cats, it exhibited a long-lasting inhibitory effect comparable or superior to the effects of salmeterol and formoterol. These data indicate that, among the known β_2-adrenoceptor agonists examined, TA-2005 exerts the most potent bronchodilating effects with a long duration of action in vivo, and its potency ratios to the other reference drugs were greater in antigen-than spasmogen-induced bronchoconstric-tion models.
- 社団法人日本薬学会の論文
- 1994-08-15
著者
-
池沢 一郎
田辺製薬・創薬研究所
-
吉川 日出雄
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
菅野 賢吉
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
池沢 一郎
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
吉川 日出雄
田辺製薬(株)創薬研究所
-
菅野 賢吉
Pharmacological Research Laboratory Tanabe Seiyaku Co. Ltd.
関連論文
- 276 ラットにおけるSephadex G-200誘発気道過敏性亢進ならびに気道内炎症に対するdexamethasoneおよびcyclosporin Aの影響
- 275 ラットにおけるSephadex G-200誘発気道過敏性亢進モデルの経時的変化
- 173 ラットにおけるSephadex G-200誘発気道過敏性亢進モデル関する検討 : ラットの系統差ならびにdexmethasoneの影響について
- 462 モノクローナルCD4^+T細胞による気道過敏性亢進反応を伴う好酸球性炎症の解析
- 145 non-transformedヒトT細胞におけるIL-5遺伝子転写制御
- 301 新規抗喘息薬T-440のホスホジエステラーゼ阻害作用およびモルモット好酸球の機能に対する作用
- 300 新規抗喘息薬T-440のモルモット気管支喘息モデルに対する作用
- TA-2005,a Novel, Long-Acting, and Selective β_2-Adrenoceptor Agonist : Characterization of Its in Vivo Bronchodilating Action in Guinea Pigs and Cats in Comparison with Other β_2-Agonists
- 1. IL-5産生性T細胞による好酸球性炎症の発症 (4 好酸球 : その2 : 産生, 浸潤)
- 90 気管支喘息におけるTh2 cellの浸潤反応